Difference between revisions of "Uterus"
Jump to navigation
Jump to search
(17 intermediate revisions by the same user not shown) | |||
Line 24: | Line 24: | ||
Notes: | Notes: | ||
*There are almost no quality of life differences between total & subtotal hysterectomy.<ref name=pmid12397189>{{Cite journal | last1 = Thakar | first1 = R. | last2 = Ayers | first2 = S. | last3 = Clarkson | first3 = P. | last4 = Stanton | first4 = S. | last5 = Manyonda | first5 = I. | title = Outcomes after total versus subtotal abdominal hysterectomy. | journal = N Engl J Med | volume = 347 | issue = 17 | pages = 1318-25 | month = Oct | year = 2002 | doi = 10.1056/NEJMoa013336 | PMID = 12397189 }}</ref> | *There are almost no quality of life differences between total & subtotal hysterectomy.<ref name=pmid12397189>{{Cite journal | last1 = Thakar | first1 = R. | last2 = Ayers | first2 = S. | last3 = Clarkson | first3 = P. | last4 = Stanton | first4 = S. | last5 = Manyonda | first5 = I. | title = Outcomes after total versus subtotal abdominal hysterectomy. | journal = N Engl J Med | volume = 347 | issue = 17 | pages = 1318-25 | month = Oct | year = 2002 | doi = 10.1056/NEJMoa013336 | PMID = 12397189 }}</ref> | ||
*''Simple hysterectomy'' is removal of the uterus and cervix;<ref>{{Cite journal | last1 = Somashekhar | first1 = SP. | last2 = Ashwin | first2 = KR. | title = Management of Early Stage Cervical Cancer. | journal = Rev Recent Clin Trials | volume = | issue = | pages = | month = Sep | year = 2015 | doi = | PMID = 26411950 }}</ref> it can be used as a synonym for ''total hysterectomy''.<ref>URL: [http://www.baymoon.com/~gyncancer/library/glossary/bldefhyster.htm http://www.baymoon.com/~gyncancer/library/glossary/bldefhyster.htm]. Accessed on: 8 October 2015.</ref> | |||
==Grossing hysterectomy specimens== | |||
*[[Hysterectomy for endometrial cancer grossing]]. | |||
*[[Hysterectomy for endometrial hyperplasia grossing]]. | |||
*[[Hysterectomy for fibroids grossing]]. | |||
===Hysterectomy specimens - orientation=== | |||
Orientation: | |||
*Less peritoneum on anterior (as the [[urinary bladder]] is there). | |||
**'''P'''osterior '''p'''eritoneal edge: '''p'''ointy (upside down triangle). | |||
***Anterior peritoneal edge: rounded/non-pointy. | |||
*Tubes on anterior-lateral aspect.<ref>{{Ref Lester3|425}}</ref> | |||
**Round ligaments posterior to tubes. | |||
=Normal uterine wall= | =Normal uterine wall= | ||
Line 87: | Line 101: | ||
==Uterine adenomyosis== | ==Uterine adenomyosis== | ||
*[[AKA]] ''adenomyosis of the uterus''. | *[[AKA]] ''adenomyosis of the uterus''. | ||
{{Main|Uterine adenomyosis}} | |||
==Uterine prolapse== | ==Uterine prolapse== | ||
:''Urogenital prolapse'' redirects here. | :''Urogenital prolapse'' redirects here. | ||
{{main|Uterine prolapse}} | |||
==Dysfunctional uterine bleeding== | ==Dysfunctional uterine bleeding== | ||
Line 231: | Line 121: | ||
===Sign out=== | ===Sign out=== | ||
<pre> | |||
Uterus, Cervix, and Bilateral Uterine Tubes, Total Hysterectomy and Bilateral Salpingectomy: | |||
- Uterine cervix within normal limits. | |||
- Proliferative phase endometrium with focal fibrosis, compatible with prior ablation. | |||
- Uterine leiomyomas. | |||
- Bilateral uterine tubes without significant pathology. | |||
- NEGATIVE for malignancy. | |||
</pre> | |||
====Block letters==== | |||
<pre> | <pre> | ||
A. OMENTUM, BIOPSY: | A. OMENTUM, BIOPSY: | ||
Line 247: | Line 147: | ||
- BILATERAL UTERINE TUBES WITHOUT SIGNIFICANT PATHOLOGY. | - BILATERAL UTERINE TUBES WITHOUT SIGNIFICANT PATHOLOGY. | ||
- NEGATIVE FOR MALIGNANCY. | - NEGATIVE FOR MALIGNANCY. | ||
</pre> | |||
==BRCA carrier== | |||
===General=== | |||
*Prophylatic bilateral salpingo-oophorectomies (BSOs) done in [[BRCA1|BRCA carrier]]s to reduce risk of [[serous carcinoma]].<ref name=pmid27241111>{{Cite journal | last1 = Shaw | first1 = PA. | last2 = Clarke | first2 = BA. | title = Prophylactic Gynecologic Specimens from Hereditary Cancer Carriers. | journal = Surg Pathol Clin | volume = 9 | issue = 2 | pages = 307-28 | month = Jun | year = 2016 | doi = 10.1016/j.path.2016.02.002 | PMID = 27241111 }}</ref> | |||
Incidence of pathology in prophylatic BSOs in a series of 226 cases:<ref name=pmid22710074>{{Cite journal | last1 = Mingels | first1 = MJ. | last2 = Roelofsen | first2 = T. | last3 = van der Laak | first3 = JA. | last4 = de Hullu | first4 = JA. | last5 = van Ham | first5 = MA. | last6 = Massuger | first6 = LF. | last7 = Bulten | first7 = J. | last8 = Bol | first8 = M. | title = Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls. | journal = Gynecol Oncol | volume = 127 | issue = 1 | pages = 88-93 | month = Oct | year = 2012 | doi = 10.1016/j.ygyno.2012.06.015 | PMID = 22710074 }}</ref> | |||
*Invasive carcinoma ~ 0.9%. | |||
*STIC ~ 6.2% | |||
===Grossing=== | |||
*In prophylatic procedures, the ovaries and tubes, endometrium, and lower uterine segment should all be [[submitted in total]].<ref name=pmid24495259>{{Cite journal | last1 = Downes | first1 = MR. | last2 = Allo | first2 = G. | last3 = McCluggage | first3 = WG. | last4 = Sy | first4 = K. | last5 = Ferguson | first5 = SE. | last6 = Aronson | first6 = M. | last7 = Pollett | first7 = A. | last8 = Gallinger | first8 = S. | last9 = Bilbily | first9 = E. | title = Review of findings in prophylactic gynaecological specimens in Lynch syndrome with literature review and recommendations for grossing. | journal = Histopathology | volume = 65 | issue = 2 | pages = 228-39 | month = Aug | year = 2014 | doi = 10.1111/his.12386 | PMID = 24495259 }}</ref> | |||
===Microscopic=== | |||
DDx: | |||
*Early [[serous carcinoma]] of the fallopian tube or ovary. | |||
*[[STIC]]. | |||
===IHC=== | |||
*p53 -ve. | |||
*p16 -ve. | |||
*Ki-67 low. | |||
===Sign out=== | |||
<pre> | |||
Uterus, Cervix, Fallopian Tubes and Ovaries, Total Abdominal Hysterectomy and Bilateral Salpingo-Oophorectomy: | |||
- Uterus with fibrous serosal adhesions. | |||
- Cervix within normal limits. | |||
- Atherosclerosis, moderate. | |||
- Inactive endometrium with cystic changes. | |||
- Uterine adenomyosis. | |||
- Fallopian tubes within normal limits. | |||
- Ovaries with benign cysts. | |||
- NEGATIVE for malignancy. | |||
</pre> | </pre> | ||
Latest revision as of 19:33, 6 June 2018
The uterus is essential for survival of the species. It is commonly afflicted with tumours.
Endometrium and its pathology is dealt with in the endometrium, endometrial hyperplasia and endometrial carcinoma articles.
Other tumours are dealt with in uterine tumours.
Operations
- Myomectomy.
- Indication: uterine leiomyomas.
- Subtotal hysterectomy.
- Discouraged... as the cervix remains and can develop a cancer.
- Total hysterectomy.
- Indications:
- Endometrial cancer (low stage, good histologic type), endometrial hyperplasia.
- Uterine prolapse.
- Uterine adenomyosis.
- Uterine leiomyomas.
- Chronic pelvic pain.[1]
- Indications:
- Radical hysterectomy - total hysterectomy + parametrial tissue.[2]
- Indications: cervical cancers, advanced uterine cancers.
- This is typically done by gynecologists with additional training at larger centres.
- Usually done with a bilateral salpingo-opherectomy (both tubes and ovaries) and pelvic lymph node dissection.
- Indications: cervical cancers, advanced uterine cancers.
Notes:
- There are almost no quality of life differences between total & subtotal hysterectomy.[3]
- Simple hysterectomy is removal of the uterus and cervix;[4] it can be used as a synonym for total hysterectomy.[5]
Grossing hysterectomy specimens
- Hysterectomy for endometrial cancer grossing.
- Hysterectomy for endometrial hyperplasia grossing.
- Hysterectomy for fibroids grossing.
Hysterectomy specimens - orientation
Orientation:
- Less peritoneum on anterior (as the urinary bladder is there).
- Posterior peritoneal edge: pointy (upside down triangle).
- Anterior peritoneal edge: rounded/non-pointy.
- Posterior peritoneal edge: pointy (upside down triangle).
- Tubes on anterior-lateral aspect.[6]
- Round ligaments posterior to tubes.
Normal uterine wall
Gross
- Firm.
- Pear-shaped.
- Not quite true -- it is usu. flattened at the anterior and posterior.
Negatives:
- No nodules.
- No trabeculations.
Microsopic
Features:
- Smooth muscle arranged in fascicles.
IHC
- ER +ve.
- PR +ve.
Tumours of the corpus
Main article: Uterine tumours
The most common is leiomyoma (uterine fibroids).
Endometrium
Main article: Endometrium
Dealt with in endometrium, endometrial hyperplasia and endometrial carcinoma articles.
Specific conditions
Congenital absence of the uterus
General
- Often associated with absence of the deep portion of the vagina; thus, may be congenital absence of the uterus and vagina (CAUV).
- May go by the name Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome.[7]
- May be seen in the context of Müllerian agenesis. (???)
Features:[7]
- Subdivided - as etiologies differ.
- Thought to have a genetic component - autosomal dominant with variable penetration.
Treatment:
- Uterine transplant - attempted.[8]
Uterus didelphys
General
- Benign - though may adversely affect fertility.[9]
- Rare - seen in < 0.3% deliveries.[10]
- Can be thought of as double uterus - a consequence of the Muellerian ducts not fusing.
Related conditions:
- Arcuate uterus - fundus has a concave contour towards the uterine cavity.
- Septate uterus.
- Bicornuate uterus.
- Uterus didelphys.
Image:
Gross
- Two uteri - each have a cervix, each connect to one fallopian tube/ovary.
- +/-Vaginal septum or double vagina.[10]
Microscopic
- Non-specific - gross diagnosis.
Uterine adenomyosis
- AKA adenomyosis of the uterus.
Main article: Uterine adenomyosis
Uterine prolapse
- Urogenital prolapse redirects here.
Main article: Uterine prolapse
Dysfunctional uterine bleeding
- Abbreviated DUB.
General
- Clinical diagnosis based on negative pathology - specifically a negative endometrial biopsy.
Clinical:
Microscopic
Features:
- Endometrium within normal limits - see proliferative phase endometrium and secretory phase endometrium.
Sign out
Uterus, Cervix, and Bilateral Uterine Tubes, Total Hysterectomy and Bilateral Salpingectomy: - Uterine cervix within normal limits. - Proliferative phase endometrium with focal fibrosis, compatible with prior ablation. - Uterine leiomyomas. - Bilateral uterine tubes without significant pathology. - NEGATIVE for malignancy.
Block letters
A. OMENTUM, BIOPSY: - FIBROADIPOSE TISSUE WITHIN NORMAL LIMITS -- CONSISTENT WITH OMENTUM. B. UTERUS, SUBTOTAL HYSTERECTOMY: - SECRETORY PHASE ENDOMETRIUM. - UTERINE WALL WITHIN NORMAL LIMITS.
UTERUS, CERVIX, AND BILATERAL UTERINE TUBES, TOTAL HYSTERECTOMY AND BILATERAL SALPINGECTOMY: - UTERINE CERVIX WITHIN NORMAL LIMITS. - PROLIFERATIVE PHASE ENDOMETRIUM WITH FOCAL FIBROSIS, COMPATIBLE WITH PRIOR ABLATION. - UTERINE LEIOMYOMAS. - BILATERAL UTERINE TUBES WITHOUT SIGNIFICANT PATHOLOGY. - NEGATIVE FOR MALIGNANCY.
BRCA carrier
General
- Prophylatic bilateral salpingo-oophorectomies (BSOs) done in BRCA carriers to reduce risk of serous carcinoma.[12]
Incidence of pathology in prophylatic BSOs in a series of 226 cases:[13]
- Invasive carcinoma ~ 0.9%.
- STIC ~ 6.2%
Grossing
- In prophylatic procedures, the ovaries and tubes, endometrium, and lower uterine segment should all be submitted in total.[14]
Microscopic
DDx:
- Early serous carcinoma of the fallopian tube or ovary.
- STIC.
IHC
- p53 -ve.
- p16 -ve.
- Ki-67 low.
Sign out
Uterus, Cervix, Fallopian Tubes and Ovaries, Total Abdominal Hysterectomy and Bilateral Salpingo-Oophorectomy: - Uterus with fibrous serosal adhesions. - Cervix within normal limits. - Atherosclerosis, moderate. - Inactive endometrium with cystic changes. - Uterine adenomyosis. - Fallopian tubes within normal limits. - Ovaries with benign cysts. - NEGATIVE for malignancy.
See also
References
- ↑ Lamvu, G. (May 2011). "Role of hysterectomy in the treatment of chronic pelvic pain.". Obstet Gynecol 117 (5): 1175-8. doi:10.1097/AOG.0b013e31821646e1. PMID 21508759.
- ↑ Frumovitz, M.; Sun, CC.; Schmeler, KM.; Deavers, MT.; Dos Reis, R.; Levenback, CF.; Ramirez, PT. (Jul 2009). "Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer.". Obstet Gynecol 114 (1): 93-9. doi:10.1097/AOG.0b013e3181ab474d. PMID 19546764.
- ↑ Thakar, R.; Ayers, S.; Clarkson, P.; Stanton, S.; Manyonda, I. (Oct 2002). "Outcomes after total versus subtotal abdominal hysterectomy.". N Engl J Med 347 (17): 1318-25. doi:10.1056/NEJMoa013336. PMID 12397189.
- ↑ Somashekhar, SP.; Ashwin, KR. (Sep 2015). "Management of Early Stage Cervical Cancer.". Rev Recent Clin Trials. PMID 26411950.
- ↑ URL: http://www.baymoon.com/~gyncancer/library/glossary/bldefhyster.htm. Accessed on: 8 October 2015.
- ↑ Lester, Susan Carole (2010). Manual of Surgical Pathology (3rd ed.). Saunders. pp. 425. ISBN 978-0-323-06516-0.
- ↑ 7.0 7.1 URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1832178/.
- ↑ URL: http://singularityhub.com/2011/06/18/in-a-medical-first-infertile-daughter-will-receive-uterus-from-mother-video/. Accessed on: 17 June 2011.
- ↑ Taylor, E.; Gomel, V. (Jan 2008). "The uterus and fertility.". Fertil Steril 89 (1): 1-16. doi:10.1016/j.fertnstert.2007.09.069. PMID 18155200.
- ↑ 10.0 10.1 Brown, DC.; Nelson, RF. (Mar 1967). "Uterus didelphys and double vagina with delivery of a normal infant from each uterus.". Can Med Assoc J 96 (11): 675-7. PMC 1936081. PMID 6019679. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936081/.
- ↑ URL: http://www.msdlatinamerica.com/ebooks/RadiologyReviewManual/sid1652818.html. Accessed on: 28 April 2012.
- ↑ Shaw, PA.; Clarke, BA. (Jun 2016). "Prophylactic Gynecologic Specimens from Hereditary Cancer Carriers.". Surg Pathol Clin 9 (2): 307-28. doi:10.1016/j.path.2016.02.002. PMID 27241111.
- ↑ Mingels, MJ.; Roelofsen, T.; van der Laak, JA.; de Hullu, JA.; van Ham, MA.; Massuger, LF.; Bulten, J.; Bol, M. (Oct 2012). "Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls.". Gynecol Oncol 127 (1): 88-93. doi:10.1016/j.ygyno.2012.06.015. PMID 22710074.
- ↑ Downes, MR.; Allo, G.; McCluggage, WG.; Sy, K.; Ferguson, SE.; Aronson, M.; Pollett, A.; Gallinger, S. et al. (Aug 2014). "Review of findings in prophylactic gynaecological specimens in Lynch syndrome with literature review and recommendations for grossing.". Histopathology 65 (2): 228-39. doi:10.1111/his.12386. PMID 24495259.